RVTY Stock Overview
Provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Narratives bring a range of perspectives from our community.
Revvity, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$112.56 |
52 Week High | US$129.50 |
52 Week Low | US$97.32 |
Beta | 1.03 |
1 Month Change | 0.47% |
3 Month Change | -7.79% |
1 Year Change | 4.50% |
3 Year Change | -41.91% |
5 Year Change | 15.98% |
Change since IPO | 3,298.04% |
Recent News & Updates
Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching
Dec 19Safe Biopharma: Revvity's Recurring Revenues And Diagnostics
Dec 16Estimating The Intrinsic Value Of Revvity, Inc. (NYSE:RVTY)
Dec 01We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative
Nov 13Recent updates
Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching
Dec 19Safe Biopharma: Revvity's Recurring Revenues And Diagnostics
Dec 16Estimating The Intrinsic Value Of Revvity, Inc. (NYSE:RVTY)
Dec 01We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative
Nov 13Here's Why Revvity (NYSE:RVTY) Can Manage Its Debt Responsibly
Oct 24Getting In Cheap On Revvity, Inc. (NYSE:RVTY) Might Be Difficult
Aug 21When Should You Buy Revvity, Inc. (NYSE:RVTY)?
Jul 16Revvity: Continued Struggles, 2024 Becoming A Lost Year
Jul 03Is Revvity (NYSE:RVTY) Using Too Much Debt?
Jun 10Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price
Apr 03Revvity: Enter Now As Reorganization Takes Shape
Mar 21We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt
Feb 28Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality
Feb 13Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?
Jan 19An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued
Jan 04Revvity: More Than A Name Change Is Needed For PerkinElmer
Dec 29Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade)
Oct 04Revvity: New Name - But New Investment Outlook? Reiterate Buy
Jul 18Shareholder Returns
RVTY | US Life Sciences | US Market | |
---|---|---|---|
7D | -2.9% | -2.1% | -2.4% |
1Y | 4.5% | -5.5% | 23.3% |
Return vs Industry: RVTY exceeded the US Life Sciences industry which returned -5.5% over the past year.
Return vs Market: RVTY underperformed the US Market which returned 23.3% over the past year.
Price Volatility
RVTY volatility | |
---|---|
RVTY Average Weekly Movement | 3.8% |
Life Sciences Industry Average Movement | 9.2% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RVTY has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: RVTY's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1937 | 11,500 | Prahlad Singh | www.revvity.com |
Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Revvity, Inc. Fundamentals Summary
RVTY fundamental statistics | |
---|---|
Market cap | US$13.70b |
Earnings (TTM) | US$258.26m |
Revenue (TTM) | US$2.72b |
53.0x
P/E Ratio5.0x
P/S RatioIs RVTY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RVTY income statement (TTM) | |
---|---|
Revenue | US$2.72b |
Cost of Revenue | US$1.21b |
Gross Profit | US$1.51b |
Other Expenses | US$1.25b |
Earnings | US$258.26m |
Last Reported Earnings
Sep 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 2.12 |
Gross Margin | 55.37% |
Net Profit Margin | 9.49% |
Debt/Equity Ratio | 40.2% |
How did RVTY perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield13%
Payout RatioDoes RVTY pay a reliable dividends?
See RVTY dividend history and benchmarksRevvity dividend dates | |
---|---|
Ex Dividend Date | Jan 17 2025 |
Dividend Pay Date | Feb 07 2025 |
Days until Ex dividend | 26 days |
Days until Dividend pay date | 47 days |
Does RVTY pay a reliable dividends?
See RVTY dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:07 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/29 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Revvity, Inc. is covered by 43 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Catherine Ramsey Schulte | Baird |
Ishan Majumdar | Baptista Research |
Luke Sergott | Barclays |